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Abstract
Background: Appropriate management of anxiety disorders in primary care requires clinical assessment and
monitoring of the severity of the anxiety. This study focuses on the Beck Anxiety Inventory (BAI) as a severity
indicator for anxiety in primary care patients with different anxiety disorders (social phobia, panic disorder with or
without agoraphobia, agoraphobia or generalized anxiety disorder), depressive disorders or no disorder (controls).
Methods: Participants were 1601 primary care patients participating in the Netherlands Study of Depression and
Anxiety (NESDA). Regression analyses were used to compare the mean BAI scores of the different diagnostic
groups and to correct for age and gender.
Results: Patients with any anxiety disorder had a significantly higher mean score than the controls. A significantly
higher score was found for patients with panic disorder and agoraphobia compared to patients with agoraphobia
only or social phobia only. BAI scores in patients with an anxiety disorder with a co-morbid anxiety disorder and in
patients with an anxiety disorder with a co-morbid depressive disorder were significantly higher than BAI scores in
patients with an anxiety disorder alone or patients with a depressive disorder alone. Depressed and anxious
patients did not differ significantly in their mean scores.
Conclusions: The results suggest that the BAI may be used as a severity indicator of anxiety in primary care
patients with different anxiety disorders. However, because the instrument seems to reflect the severity of
depression as well, it is not a suitable instrument to discriminate between anxiety and depression in a primary care
population.
Background
In primary care, many patients present with anxiety symp-
toms but these are seldom systematically assessed [1]. To
improve anxiety management, assessment of the severity
of the anxiety (and subsequent monitoring) is recom-
mended by researchers and also in clinical guidelines
[2-4]. With regard to depression, the use of severity indica-
tors in primary care is supported by the results of studies
showing that patients value the use of questionnaires as a
supplement to the diagnosis made by their general practi-
tioner and as evidence that their problems are taken ser-
iously [5]. Furthermore, when questionnaires to assess
severity are used, higher severity scores are related to bet-
ter care (i.e. higher prescription rates of antidepressant
medication and increased referral to secondary care) [6].
Moreover, in some countries incentives are offered when a
validated instrument is used at the start of and during the
treatment of patients diagnosed with depression [7]. For
similar reasons the use of severity scales to assess anxiety
symptoms in primary care might be advocated. However,
we first have to determine which questionnaires can be* Correspondence: amuntingh@trimbos.nl1Netherlands Institute of Mental Health and Addiction (Trimbos Institute), PO
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used as severity indicators in primary care and what their
characteristics are.
As anxiety disorders differ in type and symptoms,
assessing the severity of anxiety in general may be more
difficult than assessing the severity of depression. General
rating scales may not be specific enough to assess the
severity of a specific anxiety disorder (i.e. panic disorder
or generalized anxiety disorder). However, extensive test-
ing for different forms of anxiety is also not feasible dur-
ing the short consultations in primary care. Considering
its brevity, simplicity, and presumed ability to measure
general anxiety, the Beck Anxiety Inventory (BAI) [8]
might be a good candidate for use as a severity indicator.
Since its development, the BAI has been widely used in
clinical research in mental health care, mainly as a mea-
sure of general anxiety [9].
However, the BAI has been disputed for its focus on
psychophysiological symptoms linked to panic. The
results of several studies have found that patients with
panic disorder score higher on the BAI than patients
with for example generalized anxiety disorder [10-13].
Either way, patients with panic disorder and patients with
other anxiety disorders have been found to score signifi-
cantly higher than patients with no anxiety disorder
[14-16]. Remarkably, no study has specifically investi-
gated the co-morbidity of anxiety disorders and how this
influences BAI scores, even though co-morbidity occurs
frequently [17]. Furthermore, none of the previous BAI
studies have focused on primary care populations.
Another presumed quality of the BAI is its ability to dis-
criminate anxiety from depression [8]. Even though in pri-
mary care this might be of less importance than in
research settings, it is important to know whether the BAI
only measures anxiety or whether it is also sensitive to
depressive symptomatology. The results of earlier studies
suggest a substantial overlap of the BAI with depressive
symptoms, illustrated by a moderate correlation between
the BAI and depression scales [18]. In terms of differences
in the BAI scores of anxious and depressed patients, a
large difference was found in the original validation study
[8], but in two later studies no difference was found. How-
ever, in these studies the authors questioned the results
because of limitations in the methodology [15,19].
In the present study, we investigated whether the BAI
reflects the severity of anxiety in primary care patients
with different anxiety disorders. The mean scores of sev-
eral patient groups were compared: healthy controls,
patients with one anxiety disorder, patients with multiple
anxiety disorders, patients with one depressive disorder,
and patients with co-morbid anxiety-depression. The diag-
nostic groups were separated into patients with no co-
morbidity and patients with co-morbidity, to ensure
homogeneity of the groups. It was hypothesized that the
BAI scores of patients with an anxiety disorder would be
higher than the BAI scores of healthy controls or
depressed patients. Patients with a panic disorder were
expected to score higher than patients in the other anxiety
disorder groups. We also expected patients with co-
morbid disorders to score higher than patients with no
co-morbidity.
Methods
Participants
The participants in this study were recruited for a large
cohort study: the Netherlands Study of Depression and
Anxiety (NESDA) [20]. From the baseline sub-sample of
1601 primary care patients in the NESDA cohort we
selected all patients with a current anxiety or depressive
disorder according to the WHO Composite Interview
Diagnostic Instrument (CIDI lifetime version 2.1) and
patients with no history of anxiety or depression. DSM-
IV classifications of diagnoses within the past month
were used to assure present symptomatology. Patients
with a history of anxiety or depression, but no current
diagnosis, were excluded from the analysis. The mean
BAI scores of patients with an anxiety disorder (N =
276) and patients with a depressive disorder (N = 155),
were compared to the mean BAI scores of a control
group of patients with no history of anxiety or depres-
sive disorders (N= 513). The NESDA study protocol was
approved by the Medical Ethics Committee of the VU
University Medical Centre.
Procedures
The primary care sample in the NESDA study was
recruited between September 2004 and February 2007
through 65 general practitioners situated in different
parts of the Netherlands (Amsterdam, Groningen, and
Leiden). A screening questionnaire was sent to 23750
patients between 18 and 65 years of age who had con-
sulted their general practitioner in the past four months.
This questionnaire consisted of the Kessler-10 (K-10)
[21], which screens for affective disorders, supplemented
with five questions about anxiety (Extended K-10, or
EK-10). The EK-10 showed adequate psychometric
properties, with a sensitivity of .90 and a specificity of
.75 to detect anxiety or depressive disorders [22]. Parti-
cipants who returned the EK-10 (N = 10706, 45.9%),
scored positively (N = 4592, 43%), gave informed con-
sent (N = 3420, 74%) and could be contacted (N = 2995,
88%) had a telephone screening interview based on
short-form sections of the CIDI (major depression, dys-
thymia, social phobia, panic disorder, agoraphobia, and
generalized anxiety disorder).
Patients who were unwilling to be interviewed (N =
267, 9%), were not fluent in Dutch (N = 86, 3%) or were
being treated in a mental health organization (N = 155,
5%), were excluded. All other patients who screened
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positive on the telephone screening (N = 1162, 47%) and
a random sample of patients who screened negative
(N = 924) were contacted for a face-to-face interview.
As 437 (24%) participants were unwilling to participate
and 39 (2%) could not be contacted or were not fluent
in Dutch, 1610 primary care patients were finally
included in the NESDA study and completed the base-
line assessment. More details about the recruitment pro-
cess are described elsewhere [20]. Of the 1610 NESDA
participants, 9 patients who did not complete the BAI
were excluded from the analysis. The present sample
therefore consisted of 1601 patients, 617 of whom had
at least one current diagnosis of anxiety or depression,
471 had a history of anxiety or depression, and 513
were controls with no history of anxiety or depression.
Assessment
Composite Interview Diagnostic Instrument (CIDI)
The CIDI (version 2.1) is an interview that classifies psy-
chiatric diagnoses according to the DSM-IV [23]. It is a
widely used interview, which has good interrater reliability
[24], high test-retest reliability [25], and high validity for
the classification of depressive and anxiety disorders
[26,27]. CIDI interviews were conducted by specifically
trained research assistants. The CIDI classifies diagnoses
that were present at some point in the patients’ life (life-
time diagnoses), in the past half year and in the past
month.
Beck Anxiety Inventory (BAI)
The BAI is a short list describing 21 anxiety symptoms
such as “wobbliness in legs”, “scared” and “fear of losing
control” [8]. Respondents are asked to rate how much
each of these symptoms bothered them in the past week,
on a scale ranging from 0 (not at all) tot 3 (severely, I
could barely stand it). The total score has a minimum of 0
and a maximum of 63. The scale was validated in a sample
of 160 psychiatric outpatients with various anxiety and
depressive disorders, diagnosed with the Structured Clini-
cal Interview for DSM-III [28]. The BAI has a high inter-
nal consistency (Cronbachs a = .92) and a test-retest
reliability over one week of .75 [8].
Statistical analysis
All analyses were conducted in SPSS version 15.0 [29].
Regression analysis was performed to examine differ-
ences between group scores. The analyses were corrected
for age and gender, because age was differentially distrib-
uted over the diagnostic groups and because female
patients scored significantly higher than male patients in
the total sample. All variables were entered simulta-
neously into the analysis. The analyses were repeated
with different groups as the reference group to be able to
compare all groups.
Results
Descriptive statistics
The average age of the participants was 45.9 years and
the majority of the patients were female (68.8%). Almost
one third of the participants had been diagnosed with
an anxiety disorder in the past month (N = 493, 30.8%).
Table 1 shows the age, gender and DSM-IV diagnosis of
the participants.
Many patients with a diagnosis of an anxiety disorder
had at least one co-morbid anxiety disorder. The per-
centage of patients with a co-morbid anxiety disorder
varied over the diagnostic groups: anxiety co-morbidity
was highest in patients with panic disorder or general-
ized anxiety disorder (54%) followed by patients with
social phobia (51%) and patients with agoraphobia alone
(35%). Almost half (41%) of the patients with an anxiety
disorder also suffered from a depressive disorder, while
62% of the patients with a depressive disorder were also
diagnosed with an anxiety disorder.
Anxiety disorders
Table 2 shows the mean BAI scores of the control
group (no history of anxiety or depression), patients
with one anxiety disorder and patients with multiple
Table 1 Age, gender and current DSM-IV diagnoses of
participants (N = 1601)
N %
All participants 1601
Age [range] 45.8 [18-65]
Female gender 1102 68.8%
Any anxiety disorder 493
Age [range] 45.7 [18-65]
Female gender 346 70.2%
Social phobia* 68 13.8%
Panic disorder with agoraphobia* 42 8.5%
Panic without agoraphobia* 28 5.7%
Agoraphobia* 42 8.5%
Generalized anxiety disorder* 34 6.9%
>1 anxiety disorder 76 15.4%
Co-morbid anxiety & depression 203 41.2%
Any depressive disorder 327
Age [Range] 46.2 [18-64]
Female gender 223 68.2%
Dysthymia* 8 2.4%
Major depression* 101 30.9%
>1 depressive disorder 15 4.6%
Co-morbid depression & anxiety 203 62.1%
Patients with a history of anxiety or depression 471 29.4%
Controls (no history of anxiety or depression) 513 32.0%
*Disorder with no co-morbid anxiety disorder or co-morbid depressive
disorder
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anxiety disorders. Patients with a co-morbid depression
were excluded from this analysis (n = 203).
Patients with an anxiety disorder scored significantly
higher than the controls (p < 0.001) and patients with
multiple anxiety disorders scored considerably higher than
all other groups (p < .05). The mean BAI score of patients
with a panic disorder and agoraphobia was significantly
higher than the mean score of patients with social phobia
(p = 0.03) or agoraphobia alone (p < 0.001).
Anxiety and depressive disorders
Table 3 shows that the score of depressed patients
approximates the score of anxious patients (p = .41).
Patients with co-morbid anxiety-depression scored sig-
nificantly higher than patients with either an anxiety dis-
order or a depressive disorder alone (p < 0.001).
Discussion
The results of our study show that primary care patients
with different anxiety disorders score significantly higher
than patients with no anxiety or depressive disorder.
These results suggest that the BAI does reflect general
anxiety in primary care patients. With regard to the dif-
ferent diagnostic groups of anxiety disorders, we did
partly confirm the strong focus of the BAI on panic
symptoms [10,11]. Patients with a panic disorder and
agoraphobia scored significantly higher than patients
with agoraphobia alone or social phobia. However,
patients with a panic disorder without agoraphobia did
not score significantly higher than the other groups. The
high scores of patients with a panic disorder and agora-
phobia might thus be explained by the severity of this
specific disorder. In other studies in which the BAI was
used, greater differences were found between the group
of patients with a panic disorder and other diagnostic
groups [11-13,30,31]. One reason for this discrepancy in
findings might be the setting in which studies took
place. Most of the previous studies were conducted in
treatment centres for anxiety disorders, while the parti-
cipants in the present study were actively recruited in
primary care, also including patients with previously
undiagnosed anxiety or depression. It is likely that more
primary care patients present with less severe forms of
panic disorder. Indeed, the mean score of patients with
panic disorder in the present study seems to be substan-
tially lower than the scores reported in studies with sec-
ondary care patients [11,13,30,31] coming closer to the
scores of patients with a panic disorder in an epidemio-
logical sample [32]. Furthermore, in the analysis of the
present study, patient groups were specifically selected
on the basis of (the absence of) co-morbidity, thus
resulting in pure diagnostic groups. This may have pro-
vided a more accurate estimate of the mean scores of
specific patient groups.
Beck and colleagues [8] claimed that the BAI measures
anxiety while minimizing its overlap with depression but
this was not sustained by the results of the present study.
For practical purposes, this is a two-sided finding. The
BAI appears to be robust for depression, but not entirely
specific for anxiety in a primary care population. These
findings are consistent with the results of earlier studies
that compared the total BAI scores of depressed and
anxious patients [15,19]. Steer and colleagues relate their
findings to the low co-morbidity rate in their sample, but
this argument does not hold up in the present study.
There could be several explanations why depressed
patients score almost as high as anxiety patients. First of
all, sub-threshold anxiety experienced by patients with a
depressive disorder may have increased their anxiety
scores. Sub-threshold anxiety was not assessed in the pre-
sent study, but previous research has shown that a sub-
stantial number of depressed patients also experience
some form of (sub-threshold) anxiety [33,34]. Secondly,
somatoform disorders were not classified with the CIDI
interview, while these disorders are prevalent in primary
care patients with a depressive disorder, and can also
cause the physiological symptoms described in the BAI
[35]. A third explanation might be that anxiety and
depression share a common underlying factor, often
referred to as ‘negative affect’ [34,36]. There is longstand-
ing debate about this question, growing stronger due to
the pressure of the upcoming publication of the DSM-V
and fuelled by the considerable prevalence of co-morbidity
between anxiety and depression and the symptom overlap
Table 2 Mean BAI scores of patients with different
anxiety disorders (with no co-morbid depression) and
controls
Diagnosis (past month) N M SD
Controls 513 4.09 5.06
Social phobia* 68 12.97 9.03
Panic disorder with agoraphobia* 42 16.00 11.02
Panic disorder without agoraphobia* 28 13.04 6.61
Agoraphobia* 42 11.62 8.51
Generalized anxiety disorder* 34 13.15 5.67
Multiple anxiety disorders 76 18.54 8.54
*Single anxiety disorder diagnosis
Table 3 Mean BAI scores of patients with a depressive
disorder, an anxiety disorder and co-morbid anxiety-
depression
Diagnosis (past month) N M SD
Depressive disorder 109 13.34 8.72
Anxiety disorder 214 13.94 8.69
Co-morbid anxiety-depression 203 21.89 10.95
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on anxiety and depression scales. With regard to this third
hypothesis, the sensitivity of the BAI for shared sympto-
matology would be more of a quality than a deficiency.
Fourthly, total scores for self-report questionnaires, in gen-
eral, might not be precise enough to measure difficult con-
structs such as anxiety and depression. There is some
evidence that the BAI is able to discriminate between anxi-
ety and depression when items are weighted, as happens in
factor analysis [19]. However, weighting the items would
complicate the use of the BAI to such an extent that its
use would not be feasible in primary care.
A strength of this study is the large size of this pri-
mary care sample, diagnosed with a valid interview iden-
tifying five different anxiety disorders and two
depressive disorders. Because of the high prevalence of
co-morbidity in patients with anxiety and depressive dis-
orders, such a large sample is needed to compare (sub-)
groups of patients with a specific anxiety or depressive
disorder. However, even in this large sample, patients
with one specific anxiety disorder are scarce, limiting
the power of the analyses. Another limitation of the
analysis was the skewed distribution of the scores.
Although we considered performing a log transforma-
tion, we decided to use raw scores to facilitate the inter-
pretability of the scores in clinical practice.
Conclusions
The results indicate that the BAI reflects the severity of
anxiety in primary care patients with different anxiety
disorders. The use of questionnaires such as the BAI may
improve the care that is provided and is desirable from
the viewpoint of primary care patients [5]. However, as
the use of questionnaires in primary care is not common
practice, this should be stimulated by means of guide-
lines, training and education. Further research will be
needed to evaluate the usefulness of the BAI in monitor-
ing the severity of anxiety during treatment and over
time. In addition, researchers should establish criteria for
improvement and remission according to the BAI score,
in primary care patients. When questionnaires such as
the BAI are used within a framework of care, such as
case management or collaborative care, they will opti-
mally help to improve the treatment of primary care
patients with anxiety disorders [3,37,38].
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